← Back to Search

Telemedicine for Schizophrenia

N/A
Waitlist Available
Led By Julie McCarthy, PhD
Research Sponsored by Mclean Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, approximately week 6-8
Awards & highlights

Study Summary

This trial is testing an intervention to help families with a loved one experiencing first episode psychosis and substance use, delivered via video conferencing. Family members will complete the sessions and give feedback to refine the treatment manual, with the goal of improving treatment engagement and reducing distress.

Eligible Conditions
  • Schizophrenia
  • Bipolar Disorder
  • Cannabis
  • Schizoaffective Disorder
  • Smoking/Cigarette Smoking
  • Psychosis
  • Substance Abuse
  • Alcoholism
  • Substance Use Disorder
  • Family
  • Nicotine Addiction
  • Psychiatric Disorder
  • Tobacco Use

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, approximately week 6-8
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention, approximately week 6-8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Sessions Completed
Secondary outcome measures
Mean Session Satisfaction Rating
Percentage of Participant Preference for In-person, Telemedicine, or Both Session Formats

Trial Design

1Treatment groups
Experimental Treatment
Group I: TelemedicineExperimental Treatment1 Intervention
Community Reinforcement and Family Training for first episode psychosis delivered via telemedicine (CRAFT-FT) with 6-8 weekly sessions of 60-minute therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CRAFT-FT
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Mclean HospitalLead Sponsor
213 Previous Clinical Trials
21,665 Total Patients Enrolled
19 Trials studying Schizophrenia
1,393 Patients Enrolled for Schizophrenia
National Institute on Drug Abuse (NIDA)NIH
2,469 Previous Clinical Trials
2,619,380 Total Patients Enrolled
50 Trials studying Schizophrenia
5,138 Patients Enrolled for Schizophrenia
Julie McCarthy, PhDPrincipal Investigator - Mclean Hospital
Mclean Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Families With Substance Use and Psychosis: A Pilot Study
Julie McCarthy, Ph.D. 2020. "Families With Substance Use and Psychosis: A Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04284813.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top